Infectious Complications in Patients With Chronic Lymphocytic Leukemia: Pathogenesis, Spectrum of Infection, and Approaches to Prophylaxis
- 1 October 2009
- journal article
- review article
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 9 (5) , 365-370
- https://doi.org/10.3816/clm.2009.n.071
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- The effect of immunoglobulin VH gene mutation status and other prognostic factors on the incidence of major infections in patients with chronic lymphocytic leukemiaCancer, 2006
- Single-agent purine analogues for the treatment of chronic lymphocytic leukaemia: A systematic review and meta-analysisCancer Treatment Reviews, 2006
- Infectious Complications of Chronic Lymphocytic LeukemiaSeminars in Oncology, 2006
- Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemiaBlood, 2005
- Similar Humoral Immunity Parameters in Chronic Lymphocytic Leukemia Patients Independent of VH Gene Mutation StatusLeukemia & Lymphoma, 2004
- Disease activity and pretreatment, rather than hypogammaglobulinaemia, are major risk factors for infectious complications in patients with chronic lymphocytic leukaemiaBritish Journal of Haematology, 2003
- Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patientsBlood, 2001
- Impact of Therapy With Chlorambucil, Fludarabine, or Fludarabine Plus Chlorambucil on Infections in Patients With Chronic Lymphocytic Leukemia: Intergroup Study Cancer and Leukemia Group B 9011Journal of Clinical Oncology, 2001
- Infections in Patients with Chronic Lymphocytic Leukemia Treated with FludarabineAnnals of Internal Medicine, 1998
- Infectious and immunosuppressive complications of purine analog therapy.Journal of Clinical Oncology, 1995